US FDA committee approves snuff reduced-risk claim

A science committee at the FDA has approved a reduced-risk claim for snuff, a decision which may raise hopes that the agency is willing to accept some tobacco products as safer than others ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik